PURPOSE: The objective was to conduct an analysis of sleep duration and risk of selected site-specific and groups of cancer among a large prospective cohort of California women. METHODS: The study population was comprised of 101,609 adult females participating in the California Teachers Study. All sites of invasive cancer prospectively diagnosed from baseline (1995-1996) through 2011 were identified through linkage to the California Cancer Registry (n = 12,322). Site-specific analyses focused on the following cancers: breast (n = 5,053), colorectal (n = 983), lung (n = 820), melanoma (n = 749), and endometrial (n = 957). Additionally, we evaluated a group of estrogen-mediated cancers consisting of breast, endometrial, and ovarian cancer (n = 6,458). Sleep duration was based on self-report of average time sleeping in the year prior to baseline. Cox proportional hazard models were used to calculate adjusted hazard ratios and 95 % confidence intervals (HRs, 95 % CI). RESULTS: Point estimates for all sites and site-specific cancers generally were near or below one for short sleepers (<6 h/night) and above one for long sleepers (10+ h/night); confidence intervals, however, were wide and included unity. Compared to average sleepers (7-9 h/night), long sleepers had an increased risk of the group of estrogen-mediated cancers (HR 1.22, 95 % CI 0.97-1.54, p (trend) = 0.04). CONCLUSIONS: These analyses suggest that longer sleep may be associated with increased risks of estrogen-mediated cancers. Further studies with more refined measures of sleep duration and quality are warranted.
PURPOSE: The objective was to conduct an analysis of sleep duration and risk of selected site-specific and groups of cancer among a large prospective cohort of California women. METHODS: The study population was comprised of 101,609 adult females participating in the California Teachers Study. All sites of invasive cancer prospectively diagnosed from baseline (1995-1996) through 2011 were identified through linkage to the California Cancer Registry (n = 12,322). Site-specific analyses focused on the following cancers: breast (n = 5,053), colorectal (n = 983), lung (n = 820), melanoma (n = 749), and endometrial (n = 957). Additionally, we evaluated a group of estrogen-mediated cancers consisting of breast, endometrial, and ovarian cancer (n = 6,458). Sleep duration was based on self-report of average time sleeping in the year prior to baseline. Cox proportional hazard models were used to calculate adjusted hazard ratios and 95 % confidence intervals (HRs, 95 % CI). RESULTS: Point estimates for all sites and site-specific cancers generally were near or below one for short sleepers (<6 h/night) and above one for long sleepers (10+ h/night); confidence intervals, however, were wide and included unity. Compared to average sleepers (7-9 h/night), long sleepers had an increased risk of the group of estrogen-mediated cancers (HR 1.22, 95 % CI 0.97-1.54, p (trend) = 0.04). CONCLUSIONS: These analyses suggest that longer sleep may be associated with increased risks of estrogen-mediated cancers. Further studies with more refined measures of sleep duration and quality are warranted.
Authors: Leslie Bernstein; Mark Allen; Hoda Anton-Culver; Dennis Deapen; Pamela L Horn-Ross; David Peel; Richard Pinder; Peggy Reynolds; Jane Sullivan-Halley; Dee West; William Wright; Al Ziogas; Ronald K Ross Journal: Cancer Causes Control Date: 2002-09 Impact factor: 2.506
Authors: Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno Journal: Sleep Date: 2009-04 Impact factor: 5.849
Authors: Sanjay R Patel; Najib T Ayas; Mark R Malhotra; David P White; Eva S Schernhammer; Frank E Speizer; Meir J Stampfer; Frank B Hu Journal: Sleep Date: 2004-05-01 Impact factor: 5.849
Authors: Susan Hurley; David O Nelson; Erika Garcia; Robert Gunier; Andrew Hertz; Peggy Reynolds Journal: Int J Health Geogr Date: 2013-08-30 Impact factor: 3.918
Authors: M Kakizaki; S Kuriyama; T Sone; K Ohmori-Matsuda; A Hozawa; N Nakaya; S Fukudo; I Tsuji Journal: Br J Cancer Date: 2008-09-23 Impact factor: 7.640
Authors: S R Patel; T Blackwell; S Redline; S Ancoli-Israel; J A Cauley; T A Hillier; C E Lewis; E S Orwoll; M L Stefanick; B C Taylor; K Yaffe; K L Stone Journal: Int J Obes (Lond) Date: 2008-10-21 Impact factor: 5.095
Authors: Elizabeth E Devore; Jennifer Massa; Kyriaki Papantoniou; Eva S Schernhammer; Kana Wu; Xuehong Zhang; Walter C Willett; Charles S Fuchs; Andrew T Chan; Shuji Ogino; Edward Giovannucci; Esther K Wei Journal: Int J Colorectal Dis Date: 2017-01-17 Impact factor: 2.571
Authors: Tiffany A Katz; Anna H Wu; Frank Z Stanczyk; Renwei Wang; Woon-Puay Koh; Jian-Min Yuan; Steffi Oesterreich; Lesley M Butler Journal: Cancer Causes Control Date: 2017-11-09 Impact factor: 2.506
Authors: Kathryn E Royse; Hashem B El-Serag; Liang Chen; Donna L White; Lauren Hale; Haleh Sangi-Haghpeykar; Li Jiao Journal: J Womens Health (Larchmt) Date: 2017-09-21 Impact factor: 2.681
Authors: Jason Y Wong; Bryan A Bassig; Roel Vermeulen; Wei Hu; Bofu Ning; Wei Jie Seow; Bu-Tian Ji; George S Downward; Hormuzd A Katki; Francesco Barone-Adesi; Nathaniel Rothman; Robert S Chapman; Qing Lan Journal: Cancer Prev Res (Phila) Date: 2017-04-04
Authors: Alexandra J White; Clarice R Weinberg; Yong-Moon Park; Aimee A D'Aloisio; Emily Vogtmann; Hazel B Nichols; Dale P Sandler Journal: Int J Cancer Date: 2017-08-22 Impact factor: 7.396
Authors: Ruby Fore; Jaime E Hart; Christine Choirat; Jennifer W Thompson; Kathleen Lynch; Francine Laden; Jorge E Chavarro; Peter James Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-02-25 Impact factor: 4.254
Authors: Xiaoyun Liang; Holly R Harris; Michael Hendryx; Aladdin H Shadyab; Lauren Hale; Yueyao Li; Tracy E Crane; Elizabeth M Cespedes Feliciano; Marcia L Stefanick; Juhua Luo Journal: Cancer Prev Res (Phila) Date: 2020-09-11